The research demonstrated that it is possible to boost the Aedes aegypti mosquito's natural immune response to the dengue virus.
Flaviviruses use a unique mechanism to hijack the cell's machinery to replicate themselves.
Mosquitoes can carry Zika and chikungunya viruses at the same time, and may potentially be able to infect humans with both viruses in a single bite.
This handbook is for public health practitioners, specifically at the national level. It offers a framework for developing a national contingency plan with local adaptations.
The first dengue vaccine has been approved for use in six countries.
Studies used to approve the vaccine found a higher rate of hospitalizations for dengue three years after vaccination in vaccinated children when compared to unvaccinated children.
A fact sheet for dengue.